<i>TP53</i> exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions.

Abstract

<i>TP53</i> truncating mutations are common in human tumors and are thought to give rise to p53-null alleles. Here, we show that <i>TP53</i> exon-6 truncating mutations occur at higher than expected frequencies and produce proteins that lack canonical p53 tumor suppressor activities but promote cancer cell proliferation, survival, and metastasis. Functionally and molecularly, these p53 mutants resemble the naturally occurring alternative p53 splice variant, p53-psi. Accordingly, these mutants can localize to the mitochondria where they promote tumor phenotypes by binding and activating the mitochondria inner pore permeability regulator, Cyclophilin D (CypD). Together, our studies reveal that <i>TP53</i> exon-6 truncating mutations, contrary to current beliefs, act beyond p53 loss to promote tumorigenesis, and could inform the development of strategies to target cancers driven by these prevalent mutations.